These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1306604

  • 1. Purification of a new anticoagulant protein, calphobindin III, from human placenta.
    Sato H.
    Tohoku J Exp Med; 1992 Dec; 168(4):561-72. PubMed ID: 1306604
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Isolation of calphobindin-II and its mechanism of anticoagulant activity].
    Kume K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1537-44. PubMed ID: 2531190
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Placental calcium-phospholipid binding protein (calphobindin)].
    Maki M, Shidara Y.
    Rinsho Byori; 1989 Apr; Spec No 81():229-39. PubMed ID: 2526886
    [No Abstract] [Full Text] [Related]

  • 8. Ca(2+)-dependent phospholipid and arachidonic acid binding by the placental annexins VI and IV.
    Edwards HC, Crumpton MJ.
    Eur J Biochem; 1991 May 23; 198(1):121-9. PubMed ID: 1828227
    [Abstract] [Full Text] [Related]

  • 9. Tissue anticoagulants in the human placenta: preliminary study with a heparin-like anticoagulant and review of the literature.
    Uszyński M.
    Gynecol Obstet Invest; 1991 May 23; 32(3):129-33. PubMed ID: 1836773
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein.
    Sammaritano LR, Gharavi AE, Soberano C, Levy RA, Lockshin MD.
    J Clin Immunol; 1992 Jan 23; 12(1):27-35. PubMed ID: 1372614
    [Abstract] [Full Text] [Related]

  • 14. Annexins and phospholipase A2 inhibition.
    Buhl WJ.
    Eicosanoids; 1992 Jan 23; 5 Suppl():S26-8. PubMed ID: 1449824
    [Abstract] [Full Text] [Related]

  • 15. Cloning and expression of cDNA for human vascular anticoagulant, a Ca2+-dependent phospholipid-binding protein.
    Maurer-Fogy I, Reutelingsperger CP, Pieters J, Bodo G, Stratowa C, Hauptmann R.
    Eur J Biochem; 1988 Jul 01; 174(4):585-92. PubMed ID: 2455636
    [Abstract] [Full Text] [Related]

  • 16. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids.
    Reutelingsperger CP, Kop JM, Hornstra G, Hemker HC.
    Eur J Biochem; 1988 Apr 05; 173(1):171-8. PubMed ID: 2965640
    [Abstract] [Full Text] [Related]

  • 17. Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein.
    Iwasaki A, Suda M, Nakao H, Nagoya T, Saino Y, Arai K, Mizoguchi T, Sato F, Yoshizaki H, Hirata M.
    J Biochem; 1987 Nov 05; 102(5):1261-73. PubMed ID: 2963810
    [Abstract] [Full Text] [Related]

  • 18. Purification and characterization of a new member of the S-100 protein family from human placenta.
    Emoto Y, Kobayashi R, Akatsuka H, Hidaka H.
    Biochem Biophys Res Commun; 1992 Feb 14; 182(3):1246-53. PubMed ID: 1540168
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Distribution and motion of calphobindin in the human body].
    Sato Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jan 14; 43(1):65-72. PubMed ID: 1825500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.